Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population.

Wei J. et al, (2021), Nat Commun, 12

Time of day of vaccination affects SARS-CoV-2 antibody responses in an observational study of healthcare workers

Wang W. et al, (2021)

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.

Payne RP. et al, (2021), Cell

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.

Pouwels KB. et al, (2021), Nat Med

Viral detection and identification in 20 min by rapid single-particle fluorescence in-situ hybridization of viral RNA.

Hepp C. et al, (2021), Sci Rep, 11

Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019.

Wang T. et al, (2021), Hepatol Commun, 5, 1586 - 1604

Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Pouwels KB. et al, (2021)

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.

Lumley SF. et al, (2021), Clin Infect Dis, 73, e699 - e709

Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time.

Walker AS. et al, (2021), Elife, 10

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Wei J. et al, (2021)

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Wei J. et al, (2021)

Enhancing epidemiological investigation of nosocomial SARS-CoV-2 infection with whole genome sequencing: A retrospective cohort study across four hospitals in the UK.

Lumley SF. et al, (2021)

Cuts to UK official development assistance budget jeopardise global viral hepatitis elimination goals.

Lemoine M. et al, (2021), Lancet Gastroenterol Hepatol, 6, 527 - 528

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study.

Wang T. et al, (2021), BMC Infect Dis, 21

Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.

Eyre DW. et al, (2021), Clin Microbiol Infect

Impact of vaccination on new SARS-CoV-2 infections in the UK

Pritchard E. et al, (2021)

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

Ogbe A. et al, (2021), Nat Commun, 12

COVID-19 CT pulmonary angiogram examinations and reported pulmonary embolism incidence: comparison between peak first wave and early second wave.

Tsakok MT. et al, (2021), Clin Radiol, 76, 310 - 312

Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing.

Peto L. et al, (2021), J Clin Microbiol

Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era

Campbell C. et al, (2021)

Load More

1
2
3
4
5
6
7
...
»